Barclays’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54
| Closed | -$29 | – | 5698 |
|
|
2024
Q4 | $29 | Sell |
54
-248
| -82% | -$173 | ﹤0.01% | 5212 |
|
|
2024
Q3 | $531 | Sell |
302
-36,097
| -99% | -$50.4K | ﹤0.01% | 5144 |
|
|
2024
Q2 | $42.6K | Sell |
36,399
-39,430
| -52% | -$98.7K | ﹤0.01% | 4264 |
|
|
2024
Q1 | $685K | Sell |
75,829
-543
| -0.7% | -$5.28K | ﹤0.01% | 3387 |
|
|
2023
Q4 | $830K | Buy |
76,372
+67,360
| +747% | +$505K | ﹤0.01% | 3583 |
|
|
2023
Q3 | $72.5K | Sell |
9,012
-48,872
| -84% | -$407K | ﹤0.01% | 3710 |
|
|
2023
Q2 | $629K | Sell |
57,884
-585,131
| -91% | -$5.01M | ﹤0.01% | 2607 |
|
|
2023
Q1 | $4.44M | Buy |
643,015
+624,860
| +3,442% | +$3.92M | ﹤0.01% | 1627 |
|
|
2022
Q4 | $72.3K | Buy |
18,155
+15,937
| +719% | +$78.3K | ﹤0.01% | 4405 |
|
|
2022
Q3 | $15K | Buy |
+2,218
| New | +$13.7K | ﹤0.01% | 4173 |
|
|
2022
Q2 | – | Sell |
-5,996
| Closed | -$56K | – | 5343 |
|
|
2022
Q1 | $56K | Buy |
+5,996
| New | +$59.6K | ﹤0.01% | 4074 |
|
|
2020
Q3 | – | Sell |
-11,684
| Closed | -$118K | – | 5685 |
|
|
2020
Q2 | $118K | Buy |
11,684
+4,852
| +71% | +$44.6K | ﹤0.01% | 4409 |
|
|
2020
Q1 | $56K | Sell |
6,832
-6,035
| -47% | -$52.3K | ﹤0.01% | 5165 |
|
|
2019
Q4 | $111K | Sell |
12,867
-1,891
| -13% | -$10.6K | ﹤0.01% | 5425 |
|
|
2019
Q3 | $91K | Buy |
14,758
+6,670
| +82% | +$53.9K | ﹤0.01% | 5548 |
|
|
2019
Q2 | $134K | Buy |
8,088
+4,754
| +143% | +$82.6K | ﹤0.01% | 5458 |
|
|
2019
Q1 | $56K | Buy |
+3,334
| New | +$48K | ﹤0.01% | 5792 |
|
|
2018
Q4 | – | Sell |
-9,639
| Closed | -$195K | – | 7441 |
|
|
2018
Q3 | $385K | Sell |
9,639
-2,125
| -18% | -$60.5K | ﹤0.01% | 4482 |
|
|
2018
Q2 | $333K | Sell |
11,764
-3,361
| -22% | -$74.5K | ﹤0.01% | 4301 |
|
|
2018
Q1 | $232K | Buy |
+15,125
| New | +$360K | ﹤0.01% | 4700 |
|